Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Rituximab And Yttrium-90 Ibritumomab Tiuxetan Radioimmunotherapy May Be Feasible Options In Patients With Low-Grade Lymphoma Of The Orbit

Bita Esmaeli,Barbara Pro,M. Wayne Saville,Peter McLaughlin

BLOOD（2005）

Cited 24|Views5
No score
Abstract
Objective: To report a cohort of patients with lymphoid tumors of the orbit, including 1 with benign lymphoid hyperplasia of the orbit whose disease responded to immunotherapy with rituximab alone or rituximab followed by Zevalin (yttrium-90 ibritumomab tiuxetan) radioimmunotherapy.
More
Translated text
Key words
lymphoma,radioimmunotherapy,rituximab,low-grade
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined